新型药物输送系统用于基于希鲁丁的产品开发和临床应用
Liqing Mo1, Can Yang1, Yingxuan Dai2
1School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, PR China; Research Center for Pharmaceutical Preparations, Hubei University of Chinese Medicine, Wuhan 430065, PR China.
International journal of biological macromolecules
|December 10, 2024
概括
希鲁丁是一种特定的血栓抑制剂,具有治疗效益,但稳定性不佳. 新型药物输送系统旨在增强希鲁丁的作用.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 药物输送系统 药物输送系统
- 生物技术是生物技术.
背景情况:
- 药用吸血虫中的多Hirudin是一种强大的血栓抑制剂,具有抗凝固,抗纤维和抗瘤的特性.
- 它对血凝素的高特异性为其提供了优势,而不是其他抗凝剂,可能减少出血的副作用.
- 临床应用受到血清稳定性差和体内蛋白酶降解的限制,降低了生物可用性和生物活性.
研究的目的:
- 系统地审查希鲁丁的临床研究,包括其分类,生物活性和临床应用.
- 突出与hirudin临床使用相关的机遇和挑战.
- 讨论旨在改善希鲁丁的生物可用性和生物活性的新型药物递送系统 (NDDS).
主要方法:
- 关于希鲁丁的临床研究的系统文献综述.
- 对希鲁丁的生物化学特性和治疗效果的分析.
- 对聚类药物递送的各种NDDS的评估.
主要成果:
- 希鲁丁具有显著的治疗潜力,但面临着与其药理动力学特征相关的挑战.
- NDDS在保护希鲁丁免受降解和增强其目标传递方面表现有前途.
- 研究表明,人们对优化各种复杂疾病的希鲁丁输送越来越感兴趣.
结论:
- 希鲁丁的独特特性使其成为一种有价值的治疗剂,但其临床实用性受到稳定性问题的阻碍.
- NDDS对于克服希鲁丁的局限性,提高其有效性和安全性至关重要.
- 传递科学的进步对于实现hirudin和其他基于多的治疗方法的全部潜力至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147
Drug Delivery: Overview
277
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
277
Drug Delivery: Miscellaneous Routes
320
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
320
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K


